Lp-PLA2 levels were above the cutoff value in all patients with T2DM and CAD in stages 3 and 2, in 3.8% of patients in stage 1 of CAD, and in 10.7% of patients with T2DM without CAD. This evidence concerns the gene PLA2G7 and type 2 diabetes mellitus.